These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6595680)

  • 1. Neuroendocrine responses to apomorphine in depressed patients and healthy control subjects.
    Jimerson DC; Cutler NR; Post RM; Rey A; Gold PW; Brown GM; Bunney WE
    Psychiatry Res; 1984 Sep; 13(1):1-12. PubMed ID: 6595680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in multihormonal responses to the dopamine agonist apomorphine between unipolar and bipolar depressed patients.
    Monreal JA; Duval F; Mokrani MC; Fattah S; Palao D
    J Psychiatr Res; 2019 May; 112():18-22. PubMed ID: 30836201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine effects of the dopamine agonist piribedil in depressed patients.
    Joffe RT; Post RM; Ballenger JC; Rebar R; Rakita R; Gold PW
    Clin Neuropharmacol; 1986; 9(5):448-55. PubMed ID: 3768867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone and prolactin response to apomorphine in bipolar and unipolar depression.
    McPherson H; Walsh A; Silverstone T
    J Affect Disord; 2003 Sep; 76(1-3):121-5. PubMed ID: 12943941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual apomorphine as a neuroendocrine probe.
    Brunerova L; Potockova J; Horacek J; Koprivova H; Rehula M; Andel M
    Psychiatry Res; 2012 Jul; 198(2):297-9. PubMed ID: 22394588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy.
    Ettigi P; Nair NP; Lal S; Cervantes P; Guyda H
    J Neurol Neurosurg Psychiatry; 1976 Sep; 39(9):870-6. PubMed ID: 993808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of carbamazepine on dopamine- and serotonin-mediated neuroendocrine responses.
    Elphick M; Yang JD; Cowen PJ
    Arch Gen Psychiatry; 1990 Feb; 47(2):135-40. PubMed ID: 2105705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal responses during insulin-induced hypoglycemia in manic-depressed, unipolar depressed, and healthy control subjects.
    Amsterdam JD; Maislin G
    J Clin Endocrinol Metab; 1991 Sep; 73(3):541-8. PubMed ID: 1874932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of the dopaminergic system in depression: clinical correlates of the apomorphine test].
    Pitchot W; Gonzalez Moreno A; Hansenne M; Wauthy J; Ansseau M
    Acta Psychiatr Belg; 1993; 93 Spec No():343-58. PubMed ID: 7916521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine effects of apomorphine: characterization of response patterns and application to schizophrenia research.
    Rotrosen J; Angrist B; Gershon S; Paquin J; Branchey L; Oleshansky M; Halpern F; Sachar EJ
    Br J Psychiatry; 1979 Nov; 135():444-56. PubMed ID: 540209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms.
    Meltzer HY; Kolakowska T; Fang VS; Fogg L; Robertson A; Lewine R; Strahilevitz M; Busch D
    Arch Gen Psychiatry; 1984 May; 41(5):512-9. PubMed ID: 6721674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine responses to levodopa in affective illness.
    Gold PW; Goodwin FK
    Lancet; 1977 May; 1(8019):1007. PubMed ID: 67442
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of ECT on the neuroendocrine response to apomorphine in severely depressed patients.
    Christie JE; Whalley LJ; Brown NS; Dick H
    Br J Psychiatry; 1982 Mar; 140():268-73. PubMed ID: 6807386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of apomorphine on blood levels of homovanillic acid, growth hormone and prolactin in medicated schizophrenics and healthy control subjects.
    Scheinin M; Syvälahti EK; Hietala J; Huupponen R; Pihlajamäki K; Seppälä OP; Säkö E
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):441-9. PubMed ID: 2866563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apomorphine induced alteration in corneofundal potentials in depression.
    Demet EM; Albers L; Sokolski KN; Chicz-Demet A; Chen CC; Reist C
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jul; 21(5):775-88. PubMed ID: 9278949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stimulation of somatotropin hormone by piribedil, a dopaminergic agonist, in endogenous depression. Preliminary study].
    Guillaume R; Charles G; Mesters P; Schittecatte M; Wilmotte J
    Acta Psychiatr Belg; 1988; 88(2):153-61. PubMed ID: 2905110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lithium on hypothalamic-pituitary dopaminergic function.
    Lal S; Nair NP; Guyda H
    Acta Psychiatr Scand; 1978 Jan; 57(1):91-6. PubMed ID: 636903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone release in depressed patients before and after recovery.
    Grégoire F; Brauman H; De Buck R; Corvilain J
    Psychoneuroendocrinology; 1977; 2(3):303-12. PubMed ID: 410051
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of dieting and weight loss on neuroendocrine responses to tryptophan, clonidine, and apomorphine in volunteers. Important implications for neuroendocrine investigations in depression.
    Goodwin GM; Fairburn CG; Cowen PJ
    Arch Gen Psychiatry; 1987 Nov; 44(11):952-7. PubMed ID: 3675135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma growth hormone and prolactin response to dopaminergic GABAmimetic and cholinergic stimulation in Huntington's disease.
    Durso R; Tamminga CA; Denaro A; Ruggeri S; Chase TN
    Neurology; 1983 Sep; 33(9):1229-32. PubMed ID: 6225034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.